Studies of the reactions of tripodal pyridine-containing ligands with Re(CO)5Br leading to rheniumtricarbonyl complexes with potential biomedical applications
作者:D. Vaughan Griffiths、Yuen-Ki Cheong、Philip Duncanson、Majid Motevalli
DOI:10.1039/c1dt11020a
日期:——
The complexes formed from the reaction of N-acylated tris-(pyridin-2-yl)methylamine (LH) with [Re(CO)5Br] depend on the structure of the ligand and the reaction conditions. Thus, while N-[1,1,1-tris-(pyridin-2-yl)methyl]acetamide coordinates through the three pyridine nitrogens to give a stable cationic complex [LHRe(CO)3Br], the analogous N-benzoyl ligand reacts under similar conditions to give a neutral complex [LRe(CO)3] with coordination through two pyridine nitrogens and a deprotonated amide. To try to explain these different outcomes, the reactions of some structurally related N-acylated [1,1-bis(pyridin-2-yl)]methylamines (L′H) with [Re(CO)5Br] have been studied and the reaction pathways identified. These studies indicate that a neutral complex [L′HRe(CO)3Br] is initially formed in which the amide portion of the ligand is uncoordinated, but that this complex under appropriate conditions then rearranges to give a cationic complex [L′HRe(CO)3]Br in which the coordinated amide nitrogen either remains protonated or is present in its imidic acid tautomeric form. Elimination of HBr from these complexes either thermally or in the presence of base then gives stable neutral complexes [L′Re(CO)3]. The impact of the N-acyl group and any substituent at the apex of the tripodal ligands (L′′H) on the relative stabilities of intermediate complexes on the reaction pathway helps provide an explanation for the observed difference in behaviour of the N-acylated tris(pyridin-2-yl)methylamines (LH).
N-酰化三-(吡啶-2-基)甲胺(LH)与[Re(CO)5Br]反应形成的配合物取决于配体的结构和反应条件。因此,虽然 N-[1,1,1-三-(吡啶-2-基)甲基]乙酰胺通过三个吡啶氮配位得到稳定的阳离子络合物 [LHRe(CO)3Br],但类似的 N-苯甲酰基配体在类似条件下反应,得到中性配合物 [LRe(CO)3],通过两个吡啶氮和去质子化酰胺进行配位。为了尝试解释这些不同的结果,我们研究了一些结构相关的 N-酰化 [1,1-双(吡啶-2-基)]甲胺 (L′H) 与 [Re(CO)5Br] 的反应,并研究了确定的反应途径。这些研究表明,最初形成中性络合物 [L'HRe(CO)3Br],其中配体的酰胺部分不配位,但该络合物在适当的条件下会重新排列,得到阳离子络合物 [L'HRe(CO) )3]Br,其中配位酰胺氮要么保持质子化,要么以其亚氨酸互变异构形式存在。通过加热或在碱存在下从这些络合物中消除 HBr,然后得到稳定的中性络合物 [L'Re(CO)3]。 N-酰基和三足配体 (L''H) 顶端的任何取代基对反应途径中中间体配合物的相对稳定性的影响有助于解释所观察到的 N-酰化基团的行为差异。三(吡啶-2-基)甲胺(LH)。